Blog

How Echo IQ Transforms Heart Disease Diagnosis with Cutting-Edge AI

by Veronica Sapp on Jan 9, 2025

EchoIQWhat does the future of heart disease detection look like?

Professor Geoff Strange, Chief Research and Strategy Officer at Echo IQ and Professor of Medicine at the University of Sydney and Notre Dame, recently sat down with the Cassling team to discuss the game-changing capabilities of EchoSolv.

EchoSolv, the groundbreaking AI platform developed by Echo IQ, is revolutionizing the detection of aortic stenosis. With its unparalleled access to extensive echocardiographic data and AI-driven analysis, EchoSolv empowers clinicians to identify aortic stenosis earlier and with greater accuracy. This reduces the risk of misdiagnoses and ensures that patients receive the timely and precise care they deserve.

In this video, Prof. Strange dives into how EchoSolv leverages cutting-edge technology to tackle one of cardiology's most challenging conditions. He also discusses how this innovative solution is not just advancing diagnostic precision but also reshaping the way healthcare providers approach heart disease treatment and patient care.


Whether you’re a cardiologist, healthcare professional or simply interested in the latest advancements in heart care, this video provides a fascinating glimpse into the transformative potential of AI in medicine.

Learn more about Echo IQ and EchoSolv here.

Meet the Author

As Cassling’s Marketing Manager, Veronica Sapp is responsible for leading Cassling’s marketing strategy through multimedia campaigns and overseeing the day-to-day operations of Cassling’s in-house marketing department. Prior to joining Cassling, Veronica served the healthcare community for nearly 10 years in a marketing career focused on medical staffing and long-term care. She earned her degree in Public Relations from the College of the Ozarks in Missouri.

Image of Author

Comments